跳至主要内容
临床试验/PACTR202102566734864
PACTR202102566734864已完成1 期

Drug-drug interaction in the co-administration of the antiretroviral drugs and the antischistomicide praziquantel

AiBST0 个研究点目标入组 32 人开始时间: 2020年5月4日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Male

入选标准

  • Black Zimbabwean
  • Age between 18 and 40 years
  • BMI between 18 and 30
  • HIV, Hepatitis B and C negative
  • Able to give consent
  • Non-smoking
  • Lab screening and ECG within the limits stipulated in the protocol
  • Healthy as determined by medical examination

排除标准

  • HIV positive
  • any current or past history of psychiatric disorder
  • subjects receiving any prescription or over the counter product
  • use of any recreational drug
  • subjects who have eaten grapefruit or drunk grapefruit juice during the last 15 days before administration of study drug
  • subjects who had xanthine containing beverages (coffee, tea, chocolates, etc) 48 hours prior to study drug administration
  • history of hepatic, renal, GI, heart, lung, neurological, endocrine, chronic infections or disease
  • subjects suffering from any acute disease at screening or check in
  • Alanine S. Transaminase (AST)/ Alanine L. Transaminase (ALT) >3 times upper limit of normal (ULN)
  • Bilirubin >2.5 times ILN
  • Amylase > 2 times ULN
  • Absolute Neutrophil Count <1000/ml
  • Hgb < 9.0g/dl
  • Platelets > 50 000 cells/mm3
  • serum creatinine >2.5 mg/dl

研究者

发起方
AiBST

相似试验